Statistics

Total Visits

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro63

Select a period of time:

Number of views in the range

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro20

Views

Views
July 20257
August 20251
September 20255
October 20252
November 20251
December 20254
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil5
United Kingdom3
Argentina1
Colombia1
Ethiopia1
France1
 

Top cities views

Views
Dallas4
Addis Ababa1
Calumet City1
Cascavel1
Curitiba1
Hicksville1
Itajaí1
Laferrere1
Leander1
Santiago de Cali1